Treatment of Sulfonamide Poisoning

Clinical Manifestations and Management

The Centers for Disease Control and Prevention recommends that treatment for sulfonamide poisoning primarily involves discontinuation of the offending agent, supportive care, and in cases of hypersensitivity reactions, alternative antimicrobial therapy with non-sulfonamide agents such as clindamycin, azithromycin, or atovaquone depending on the clinical indication 1, 2
Sulfonamide toxicity can present with hypersensitivity reactions ranging from mild rash to severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome and toxic epidermal necrolysis, with a strength of evidence supported by the Journal of Allergy and Clinical Immunology 1, 3
Bone marrow suppression, including neutropenia, anemia, and thrombocytopenia, can occur in patients with sulfonamide toxicity, as reported by the MMWR Recommendations and Reports 1, 2
Hepatotoxicity is a potential clinical manifestation of sulfonamide toxicity, with evidence provided by the MMWR Recommendations and Reports 1, 4
Gastrointestinal symptoms, such as nausea, vomiting, and diarrhea, can occur in patients with sulfonamide toxicity, according to the MMWR Recommendations and Reports 1, 2
Crystalluria is a potential complication of sulfonamide toxicity, with recommendations for management provided by the MMWR Recommendations and Reports 1, 2
Fever and leukopenia can occur in patients with sulfonamide toxicity, as reported by the MMWR Recommendations and Reports 1, 4

The American Academy of Allergy, Asthma, and Immunology recommends immediate discontinuation of the offending sulfonamide agent and provision of supportive care, including maintenance of hydration to prevent crystalluria, monitoring of complete blood counts for evidence of bone marrow suppression, and monitoring of liver function tests for hepatotoxicity 1, 2, 4
For toxoplasmosis treatment, alternative antimicrobial therapies include clindamycin, azithromycin, or atovaquone, with dosing recommendations provided by the MMWR Recommendations and Reports 1, 2
The Infectious Diseases Society of America recommends selection of alternative antibiotics based on the specific infection and susceptibility patterns for other infections typically treated with trimethoprim-sulfamethoxazole 5

The Journal of Allergy and Clinical Immunology recommends clear documentation of sulfonamide allergy in the patient's medical record and avoidance of cross-reactive sulfonamide antimicrobials 3
For patients requiring sulfonamide therapy despite a history of mild reactions, a 1-step drug challenge with TMP-SMX may be considered, with a success rate of 93-98% as reported by the Journal of Allergy and Clinical Immunology 3, 6
Induction of drug tolerance ("desensitization") protocols can be considered for patients with a history of anaphylaxis who absolutely require sulfonamide therapy, with a high success rate and recommendations for close medical supervision provided by the Journal of Allergy and Clinical Immunology 6, 7